Epratuzumab is a humanized LL2 ( hLL 2) monoclonal antibody. In phase I/ II Trial of the treatment of mantle cell lymphoma, Epratuzumab didn ′ t develope HAMA with the effective power of 18%. Epratuzumab是人源化的LL2抗体,通过对套细胞淋巴瘤的Ⅰ/Ⅱ期临床试验研究,其有效率为18%,不产生人抗鼠抗体(HAMA)。
Extracted and purified native Hll of cultivating L4 larvae and adult H.contortus from natural infection, and analyzed enzymatic activity of aminopeptidase. 对培养的L4期幼虫和自然感染的成虫的H11天然蛋白分别进行了提取和纯化,并进行了氨基肽酶活性分析。